Literature DB >> 3954932

Inability of ibuprofen to alter single dose phenytoin disposition.

K A Bachmann, J I Schwartz, R B Forney, L Jauregui, T J Sullivan.   

Abstract

The effect of ibuprofen treatment (1600 mg day-1 per os for 7 days) on single dose (300 mg per os) dispositional parameters of phenytoin (DPH) was evaluated in 10 healthy males. Ibuprofen slightly increased the free fraction of DPH from mean (+/- s.d.) value of 6.9 (+/- 0.7)% to 7.8 (+/- 0.3)% (P less than 0.01). DPH total clearance (CL/F) was not significantly changed going from a value of 0.027 (+/- 0.009) 1 h-1 kg-1 to 0.032 (+/- 0.014) 1 h-1 kg-1 (0.05 less than P less than 0.1). Intrinsic unbound DPH clearance (CLuint/F) was unaffected by ibuprofen treatment. Neither DPH's apparent volume of distribution (V/F) nor the apparent volume of distribution of unbound DPH (Vunb/F) were significantly altered by ibuprofen treatment. The slight changes in DPH plasma protein binding that are due to concurrent ibuprofen treatment in doses of 1600 mg day-1 are not likely to produce important changes in DPH dispositional parameters.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3954932      PMCID: PMC1400915          DOI: 10.1111/j.1365-2125.1986.tb05171.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  Effect of ibuprofen on protein binding of warfarin in human serum.

Authors:  J T Slattery; G Levy
Journal:  J Pharm Sci       Date:  1977-07       Impact factor: 3.534

2.  Lack of interaction between ibuprofen and warfarin.

Authors:  J A Penner; P H Abbrecht
Journal:  Curr Ther Res Clin Exp       Date:  1975-12

3.  Fluorescence polarization immunoassay IV. Determination of phenytoin and phenobarbital in human serum and plasma.

Authors:  M Lu-Steffes; G W Pittluck; M E Jolley; H N Panas; D L Olive; C H Wang; D D Nystrom; C L Keegan; T P Davis; S D Stroupe
Journal:  Clin Chem       Date:  1982-11       Impact factor: 8.327

4.  Pharmacokinetic investigation of the interaction of azapropazone with phenytoin.

Authors:  D P Geaney; J G Carver; C L Davies; J K Aronson
Journal:  Br J Clin Pharmacol       Date:  1983-06       Impact factor: 4.335

Review 5.  Drug interactions with phenytoin.

Authors:  E Perucca; A Richens
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

6.  Anticonvulsant intoxication precipitated by azapropazone.

Authors:  C J Roberts; T K Daneshmend; D Macfarlane; P A Dieppe
Journal:  Postgrad Med J       Date:  1981-03       Impact factor: 2.401

7.  Phenytoin: pharmacokinetics and bioavailability.

Authors:  R Gugler; C V Manion; D L Azarnoff
Journal:  Clin Pharmacol Ther       Date:  1976-02       Impact factor: 6.875

8.  Phenytoin as a probe of drug metabolism. Predicting clearance with a salivary sample.

Authors:  K Bachmann; J Schwartz; R Forney; L Jauregui
Journal:  Pharmacology       Date:  1985       Impact factor: 2.547

9.  Displacement of phenytoin from plasma binding sites by salicylate.

Authors:  D G Fraser; T M Ludden; R P Evens; E W Sutherland
Journal:  Clin Pharmacol Ther       Date:  1980-02       Impact factor: 6.875

10.  Phenytoin metabolism in subjects with long and short plasma half-lives.

Authors:  A J Glazko; F E Peterson; T Chang; W A Dill; T C Smith; R A Buchanan
Journal:  Ther Drug Monit       Date:  1982       Impact factor: 3.681

View more
  5 in total

Review 1.  Pharmacokinetic drug interactions with phenytoin (Part II).

Authors:  R L Nation; A M Evans; R W Milne
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

Review 2.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics of ibuprofen. The first 30 years.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

Review 4.  The problems and pitfalls of NSAID therapy in the elderly (Part II).

Authors:  A G Johnson; R O Day
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

Review 5.  Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance.

Authors:  A G Johnson; P Seideman; R O Day
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.